FDA chief pledges faster pathways for gene therapies

Tuesday could prove to be an important day for gene and cell therapy companies.

Not only did the US Food and Drug Administration (FDA) Commissioner Scott Gottlieb give a speech saying that these therapies had reached a key moment and predicting that they will soon become the mainstay of how a wide range of illness are treated.

Dr Gottlieb also promised, in his address to the Alliance for Regenerative Medicine's Annual Board Meeting, expedited development programs to help tackle some of the challenges associated with advancing these medicines.